Prelude Therapeutics (PRLD) Insider Trading & Ownership $0.96 +0.00 (+0.17%) (As of 08:48 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prelude Therapeutics (NASDAQ:PRLD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage62.80%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$5.24 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$81,273.60 Get PRLD Insider Trade Alerts Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PRLD Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Prelude Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/24/2023Krishna VaddiCEOBuy1,000$5.01$5,010.00 5/22/2023Orbimed Advisors LlcDirectorBuy869,565$5.75$4,999,998.75 4/6/2023Jane HuangCMOSell13,280$6.12$81,273.60 12/20/2022Krishna VaddiCEOBuy19,188$5.13$98,434.44 12/8/2022Laurent ChardonnetCFOBuy10,000$4.76$47,600.00 6/1/2022Laurent ChardonnetCFOBuy10,000$4.23$42,300.00 12/13/2021Andrew CombsEVPBuy4,000$12.12$48,480.00 (Data available from 1/1/2013 forward) PRLD Insider Trading Activity - Frequently Asked Questions Who is on Prelude Therapeutics's Insider Roster? The list of insiders at Prelude Therapeutics includes Andrew Combs, Jane Huang, Krishna Vaddi, Laurent Chardonnet, and Orbimed Advisors Llc. Learn more on insiders at PRLD. What percentage of Prelude Therapeutics stock is owned by insiders? 62.80% of Prelude Therapeutics stock is owned by insiders. Learn more on PRLD's insider holdings. Which Prelude Therapeutics insiders have been buying company stock? The following insiders have purchased PRLD shares in the last 24 months: Krishna Vaddi ($103,444.44), Laurent Chardonnet ($47,600.00), and Orbimed Advisors Llc ($4,999,998.75). How much insider buying is happening at Prelude Therapeutics? Insiders have purchased a total of 899,753 PRLD shares in the last 24 months for a total of $5,151,043.19 bought. Which Prelude Therapeutics insiders have been selling company stock? The following insider sold PRLD shares in the last 24 months: Jane Huang ($81,273.60). How much insider selling is happening at Prelude Therapeutics? Insiders have sold a total of 13,280 Prelude Therapeutics shares in the last 24 months for a total of $81,273.60 sold. Prelude Therapeutics Key ExecutivesDr. Krishna Vaddi D.V.M. (Age 58)Ph.D., Founder, CEO & Director Compensation: $905.92kDr. Edna Huang M.D. (Age 51)President & Chief Medical Officer Compensation: $865.63kMr. Bryant David Lim J.D. (Age 53)Interim CFO, Chief Legal Officer & Corporate Secretary Compensation: $586.42kMs. Aimee Crombie Ph.D.Senior VP and Head of Strategic Planning & OperationsDr. Madhu Pudipeddi Ph.D.Senior Vice President of Technical OperationsDr. Peggy A. Scherle Ph.D. (Age 62)Chief Scientific Officer Compensation: $868.62kLindsey TrickettVice President of Investor RelationsMs. Michele Porreca M.B.A.Chief People OfficerDr. Andrew P. Combs Ph.D. (Age 57)Executive VP & Chief Chemistry Officer Compensation: $562.46kMr. Naveen Babbar Ph.D.Senior Vice President of Translation Medicine More Insider Trading Tools from MarketBeat Related Companies Amarin Insider Trades MacroGenics Insider Trades Corbus Pharmaceuticals Insider Trades Lexeo Therapeutics Insider Trades Inhibrx Insider Trades Acrivon Therapeutics Insider Trades Editas Medicine Insider Trades Solid Biosciences Insider Trades ADC Therapeutics Insider Trades Enanta Pharmaceuticals Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:PRLD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
